| |
 
Hemostasis in wound healing. Sealants and tissue repair coats
Glyco 23 Against Sepsis
Neutrolide
Anti-ischemic agent
|
RESEARCH & DEVELOPMENT
A Magnet Company Bringing Scientists to Work Together on Challenging Technologies
Our research program began in 1999 with a partnership set up to bridge the funding and technology commercialization gap that exist between science and business. The Program expands the professional opportunities of academic-based biomedical scientists. It provides Federal, State and private industry support to academic scientists willing to collaborate in the development of challenging technologies.
Scientific Collaborators:
Maja Nowakowski, PhD
Associate Professor State University of NewYork Downstate Department of Pathology
Martin Bluth, MD, PhD
Director of Research Wayne State University
Bill LaCourse, Ph.D. Chairman and Professor of Chemistry Department of Chemistry and Biochemistry
University of Maryland Baltimore County
Aristotles Kalivretenos, PhD Chemist
Leonid Medved, Ph.D.Professor of Biochemistry and Molecular BiologyUniversity of Maryland, School of Medicine
Center for Vascular and Inflammatory Diseases
Department of Biochemistry and Molecular Biology
Jorge Fishbarg, MD Professor of Physiology Eye Instititute, School of Medicine, Columbia University, New York
Grant Bochicchio, MD PhD Professor & Director
University of Maryland Baltimore Trauma Center
Richard Sinert, MD Research Director, Emergency Medicine
SUNY Downste Medical Center
Luis Toledo Pereyra, MD PhD Professor of Surgery
Michigan State University |
The development of our platform technologies is funded by:
U.S. Army Medical Research & Material Command USAMRAA
Defense Advance Research Projects Agency (DARPA)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Heart, Lung and Blood Institute (NHLBI)
National Institute of General Medical Sciences (NIGMS)
National Institute of Allergy and Infectious Diseases (NIAID)
Johnson&Johnson/COSAT
Maryland Technology Development Corporation (TEDCO)
University of Maryland
and by private investors. |
|